Chimeric Therapeutics Limited - Neraca (Quarterly)

Chimeric Therapeutics Limited
AU ˙ ASX
A$ 0.00 ↑0.00 (50.00%)
2025-09-05
BAHAGING PRESYO
Talaan ng Balanse (Quarterly)

Neraca Chimeric Therapeutics Limited menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Cash 22 13 13 18 18 4 4 2 2 4 4 3 3 5 5 6 6
Change (%) -40.07 0.00 36.86 0.00 -80.27 0.00 -34.84 0.00 49.21 0.00 -13.40 0.00 66.00 0.00 13.60 0.00
Assets Current 23 14 14 21 21 9 9 9 9 14 14 3 3 7 7 11 11
Change (%) -38.46 0.00 51.77 0.00 -57.44 0.00 3.79 0.00 51.37 0.00 -77.24 0.00 122.01 0.00 47.15 0.00
Assets 37 28 28 35 35 23 23 22 22 27 27 15 15 19 19 22 22
Change (%) -23.06 0.00 24.18 0.00 -35.44 0.00 -0.64 0.00 19.27 0.00 -42.77 0.00 22.29 0.00 15.50 0.00
Liabilities 11 11 11 9 9 7 7 17 17 13 13 13 13 13 13 20 20
Change (%) -6.73 0.00 -13.53 0.00 -28.44 0.00 154.62 0.00 -23.27 0.00 -0.17 0.00 -0.51 0.00 53.85 0.00
Equity 25 17 17 26 26 16 16 6 6 14 14 2 2 6 6 2 2
Change (%) -30.45 0.00 47.07 0.00 -37.94 0.00 -64.52 0.00 144.90 0.00 -82.18 0.00 140.47 0.00 -66.76 0.00
Liabilities And Stock Equity 37 28 28 35 35 23 23 22 22 27 27 15 15 19 19 22 22
Change (%) -23.06 0.00 24.18 0.00 -35.44 0.00 -0.64 0.00 19.27 0.00 -42.77 0.00 22.29 0.00 15.50 0.00

Source: Capital IQ

Other Listings
US:CHMMF
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista